Glycogen storage disease type I and G6Pase-? defi ciency: etiology and therapy, Nat. Rev. Endocrinol, vol.6, pp.676-688, 2010. ,
,
Glucose-6-phosphatase defi ciency, Orphanet J. Rare Dis, vol.6, p.27, 2011. ,
Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I), Eur. J. Pediatr, vol.161, pp.20-34, 2002. ,
Nutritional therapy for glycogen storage diseases, J. Pediatr. Gastroenterol. Nutr, vol.47, pp.15-21, 2008. ,
Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas, J. Hepatol, vol.54, pp.529-537, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00575314
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J. Clin. Invest, vol.115, pp.1343-1351, 2005. ,
The role of the lipogenic pathway in the development of hepatic steatosis, Diabetes Metab, vol.34, pp.643-648, 2008. ,
Elovl6 promotes nonalcoholic steatohepatitis, Hepatology, vol.56, pp.2199-2208, 2012. ,
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes, J. Gastroenterol. Hepatol, vol.24, pp.830-840, 2009. ,
Oleate-enriched diet improves insulin sensitivity and restores muscle protein synthesis in old rats, Clin. Nutr, vol.30, pp.799-806, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02643812
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans, J. Clin. Invest, vol.122, pp.2176-2194, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02649316
Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum, Obesity (Silver Spring), vol.18, pp.937-944, 2010. ,
Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, vol.128, pp.1898-1906, 2005. ,
In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy, Biochim. Biophys. Acta, vol.1791, pp.757-763, 2009. ,
In vivo MRS measurement of liver lipid levels in mice, J. Lipid Res, vol.45, pp.1364-1371, 2004. ,
Investigation of adipose tissues in Zucker rats using in vivo and ex vivo magnetic resonance spectroscopy, J. Lipid Res, vol.52, pp.330-336, 2011. ,
In vivo NMR detection of diet-induced changes in adipose tissue composition, J. Lipid Res, vol.52, pp.833-839, 2011. ,
Longitudinal evaluation of intramyocellular lipids (IMCLs) in tibialis anterior muscle of ob/ob and ob/+ control mice using a cryogenic surface coil at 9.4 T, NMR Biomed, vol.24, pp.1295-1301, 2011. ,
In vivo phenotyping of the ob/ob mouse by magnetic resonance imaging and 1H-magnetic resonance spectroscopy, Obesity (Silver Spring), vol.14, pp.405-414, 2006. ,
In vivo monitoring of treatment effect of cryptotanshinone for non-alcoholic fatty liver disease in mice, Abstract in ISMRM-ESMRMB Joint Annual Meeting, 2010. ,
Quantifi cation of liver fat in mice: comparing dualecho Dixon imaging, chemical shift imaging, and 1H-MR spectroscopy, J. Lipid Res, vol.52, pp.1847-1855, 2011. ,
Hepatic lipid composition differs between ob/ob and ob/+ control mice as determined by using in vivo localized proton magnetic resonance spectroscopy, MAGMA, vol.25, pp.381-389, 2012. ,
Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction, Hypertension, vol.45, pp.1012-1018, 2005. ,
Time course of the development of non-alcoholic hepatic steatosis in response to high-fat diet-induced obesity in rats, Br. J. Nutr, vol.95, pp.273-281, 2006. ,
In vivo lipid profi ling using proton magnetic resonance spectroscopy in an experimental liver fi brosis model, Acad. Radiol, vol.18, pp.377-383, 2011. ,
,
Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats, Diabetes, vol.52, pp.138-144, 2003. ,
Characterizing human adipose tissue lipids by long echo time (1)H-MRS in vivo at 1.5 Tesla: validation by gas chromatography, NMR Biomed, vol.23, pp.466-472, 2010. ,
Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcriptionpolymerase chain reaction analyses, Endocrinology, vol.144, pp.4773-4782, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-02674163
Magnetic resonance imaging follow-up of liver growth of neuroendocrine tumors in an experimental mouse model, Magn. Reson. Imaging, vol.28, pp.264-272, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01918711
Effective Voigt model estimation using multiple random starting values and parameter bounds settings for in vivo hepatic 1H magnetic resonance spectroscopic data (Abstract in, 2008 IEEE International Symposium on Biomedical Imaging: From Nano to Macro, 2008. ,
Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model, Magn. Reson. Imaging, vol.30, pp.112-121, 2012. ,
Hepatic lipid profi ling in chronic hepatitis C: an in vitro and in vivo proton magnetic resonance spectroscopy study, J. Hepatol, vol.52, pp.16-24, 2010. ,
Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity, FASEB J, vol.24, pp.4366-4377, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02662422
Exploratory Data Analysis, 1977. ,
Use of Voigt lineshape for quantifi cation of in vivo 1H spectra, Magn. Reson. Med, vol.37, pp.651-657, 1997. ,
Quantifi cation of MRS data in the frequency domain using a wavelet fi lter, an approximated Voigt lineshape model and prior knowledge, NMR Biomed, vol.19, pp.617-626, 2006. ,
In vivo quantifi cation of choline compounds in the breast with 1H MR spectroscopy, Magn. Reson. Med, vol.50, pp.1134-1143, 2003. ,
Quantitative analysis of T2-correction in single-voxel magnetic resonance spectroscopy of hepatic lipid fraction, J. Magn. Reson. Imaging, vol.29, pp.629-635, 2009. ,
Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantifi cation, J. Magn. Reson. Imaging, vol.30, pp.145-152, 2009. ,
T(2) determination of the J-coupled methyl protons of lipids: in vivo illustration with tibial bone marrow at 3 T, J. Magn. Reson. Imaging, vol.31, pp.1514-1521, 2010. ,
The clinicopathologic spectrum and management of nonalcoholic fatty liver disease, Adv. Anat. Pathol, vol.9, pp.37-51, 2002. ,
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, Am. J. Physiol. Endocrinol. Metab, vol.288, pp.462-468, 2005. ,
Noninvasive quantifi cation of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy, J. Magn. Reson. Imaging, vol.32, pp.148-154, 2010. ,
Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla, J. Lipid Res, vol.49, pp.2055-2062, 2008. ,
Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy-a rapid and accurate technique, Radiology, vol.252, pp.568-576, 2009. ,
Liver fat and water MR T2 values at 3T: dependence upon steatosis level (Abstract in 19th Annual ISMRM Scientifi c Meeting and Exhibition, 2011. ,
Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts, NMR Biomed, vol.17, pp.361-381, 2004. ,
In vivo image-guided (1)H-magnetic resonance spectroscopy of the serial development of hepatocarcinogenesis in an experimental animal model, Biochim. Biophys. Acta, vol.1526, pp.230-236, 2001. ,
Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death, Cancer Res, vol.63, pp.3195-3201, 2003. ,